top of page
Neuroglide
Login to favorite a company
Automated lymphatic therapy (ALT) technology
Most Recent Valuation:
$8,997,823.00
Legal Name:
Founded:
State of HQ:
Eva Medtec, Inc.
07/07/2016
MN
Company Description
Employees:
[]
Funding Summary
Number of funding rounds
2
Total amount raised
$130,534
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
Neuroglide Common Stock 2 | 06/30/2023 | $1,430.00 | withdrawn | Common Stock | $100 | $8,997,823 | 1.2 | |
Eva Medtec Common Stock 1 | 03/21/2023 | $130,533.50 | closed | Common Stock | $299 | $11,030,000 | 1.49 |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|
Loading...
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page